Previous Hold Today ACHN ranks #3208 as HOLD CANDIDATE #3208 Next Hold

ACHN stock forecast Achillion Pharmaceuticals

ACHN stock forecast

Friday December 13, 2019 Change 0.81% Price $6.26
Your prediction: Prediction: Request
VOLUME
Sell
TREND
Buy
MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Buy

ACHN Forecast and Technical Stock Analysis


Hold candidate since 2019-12-13 PDF

Achillion Pharmaceuticals gained 0.81% in the last trading day ( Friday, 13th Dec 2019 ), rising from $6.21 to $6.26 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 0.90% from a day low at $6.22 to a day high of $6.28. The price has risen in 6 of the last 10 days and is up by 0.81% over the past 2 weeks. Volume fell in the last day by -810 693 shares and in total, 772 948 shares bought and sold for approximately $4.84 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the ACHN stock price was $6.39 and low was $6.11.
  • 90 day high was $6.46 and low was $3.48.
  • 52 week high for Achillion Pharmaceuticals - $6.46 and low - $1.29.
Top Trending Stocks

Trend

Achillion Pharmaceuticals lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. A break down the bottom trend line at $5.82 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 65.07% during the next 3 months and, with 90% probability hold a price between $9.61 and $13.92 at the end of this period.

Top Golden Star Stocks

Signals

A buy signal was issued from a pivot bottom point on Thursday November 21, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Achillion Pharmaceuticals holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $6.26. On a fall, the stock will find some support from the short-term average at $6.20. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 58 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Achillion Pharmaceuticals finds support from accumulated volume at $6.20.

Support: $6.20 Price: $6.26 Resistance: $6.27

Risk

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.06 (0.90%) between high and low. For the last week, the stock has had daily average volatility of 0.94%.

Our recommended stop-loss: $5.93 (-5.23%) (This stock has low daily movements and this gives low risk. There is a buy signal from pivot bottom found 15 days ago.)

0.94 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Hold/Accumulate Upgraded

Evaluation

Achillion Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate candidate.

Previous Hold Today ACHN ranks #3208 as HOLD CANDIDATE #3208 Next Hold
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Proudly made at

ROCKIT